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To compare the percutaneous and surgical techniques
of intraaortic balloon pump insertion, 101 patients re-
ferred for this procedure were randomly assigned to
either percutaneous or surgical insertion. Insertion using
the designated technique was successful in 45 (88%) of
51 patients with percutaneous insertion and 48 (96%)
of 50 patients with surgical insertion (difference not sta-
tistically significant). The time from the beginning of the
insertion procedure to the initiation of counterpulsation
was 13 ± 8 minutes for the percutaneous technique
versus 31 ± 16 minutes for the surgical technique (p <
0.001).
In the percutaneous group, to patients required Fo-
garty thrombectomy after balloon pump removal, and
I patient developed severe leg ischemia requiring im-
mediate termination of balloon pump support. In the
Since its initial clinical use in 1967, intraaortic balloon pump
counterpulsation has been employed with increasing fre-
quency in the treatment of patients with cardiogenic shock,
postoperative left ventricular failure, unstable angina and
postinfarction angina (I-II). For many years, balloon pump
catheter insertion required surgical exposure of the femoral
artery and removal required a second surgical procedure ( I).
Introduction of the percutaneous technique for balloon pump
catheter insertion in 1979 (12,13) allowed physicians ex-
perienced in the Seldinger method of catheterization to per-
form balloon pump insertion and removal with greater speed.
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surgical group, one patient developed leg ischemia re-
quiring surgical intervention, three patients developed
sepsis with bacteremia (including one patient who re-
quired vein patch repair of the femoral artery), one
patient developed a wound infection requiring debride-
ment and one patient had a cerebral embolus. Aortic
dissection, aortoiliac perforation or amputation did not
occur in either group. Major vascular complications oc-
curred in 11 patients (22%) with percutaneous insertion
versus 2 patients (4%) with surgical insertion (p < 0.05).
It is concluded that although the percutaneous tech-
nique for intraaortic balloon pump insertion is faster
than the surgical technique and is technically easy, it is
associated with a higher incidence of vascular compli-
cations.
(J Am Coil CardioI1987;9:515-23)
Initial studies (12-14) also suggested that the percutaneous
technique was associated with a lower complication rate.
More recent nonrandomized studies (5,15-18) have re-
ported the percutaneous complication rate to be equal to or
higher than the surgical complication rate. We have per-
formed a randomized study to compare the percutaneous
and surgical techniques in terms of complications and suc-
cess rate and speed of insertion.
Methods
Study patients. From August 1981 through June 1983,
194 patients underwent 221 intraaortic balloon pump in-
sertion procedures at Sinai Hospital of Detroit. One hundred
one of these patients participated in our randomized study.
Patients were eligible for entry into the study if intraaortic
balloon pump insertion was clinically indicated and if I) a
palpable femoral artery pulse was present, 2) there was no
history of previous aortofemoral or aortoiliac reconstructive
surgery, 3) there was no history of previous insertion or
attempted insertion of an intraaortic balloon pump, and 4)
0735-1O\l7/87/$3.50
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appropriate informed consent was given. Patients requiring
balloon pump support immediately after coronary angiog-
raphy were ex.c1uded becausea catheter was already in place
in the femoral artery and patients requiring balloon pump
insertion in the operating room after cardiac surgery were
excluded because a surgeon was already available for the
insertion procedure.
Study protocol. The study comprised a total of 101
patients. A computer-generated random sequence was uti-
lized to exclude selection bias and the study patients were
divided into three groups. Thirty-four patients were ran-
domly assigned to percutaneous insertion by a staff car-
diologist and 17 patients were assigned to percutaneous
insertion by a staff surgeon, giving a total of 51 patients
assigned to percutaneous insertion. Fifty patients were as-
signed to surgical insertion by a staff surgeon. The study
protocolwas approvedby the Sinai Hospital of DetroitMed-
ical Research Committee on January 30, 1981.
After the patients agreed to participate in the study and
gave informed consent, a sealed envelope was opened and
the randomization category was determined. Patient age,
sex, height (inches) and weight (pounds) were recorded, as
well as the indication for balloon pump insertion. Hemo-
globinand hematocritvaluesand Dopplerankle/arm systolic
pressure index values were determinedbefore balloonpump
insertion. For measurement of Doppler ankle/arm systolic
pressure index (ankle/arm index), Doppler ankle systolic
pressure was measured using a pneumatic cuff with an
8 x 40 cm inflatable bladder. Arm systolic pressure was
measured either indirectly using a sphygmomanometer for
brachial artery pressureor directly with intraarterial pressure
recording through a radial artery catheter (when available).
Ankle/arm index was calculated as the ankle systolic pres-
sure divided by the arm systolic pressure. Values were de-
termined for both lower limbs.
Balloon pump insertion. Balloon pump insertion was
then performed using the method designated by the ran-
domization process. Percutaneous balloon pump insertion
was performed using Datascope non-wire-guided catheters
(Percor) during the initial phase of the study (5 patients);
Datascope wire-guided catheters (Percor-Dl., Percor-Dl.Il)
then became available and were used subsequently (46 pa-
tients). An II inch (27.9 ern) 12F (Percor-DLII) or 12.5F
(Percor, Percor-DL) dilator-sheath combination was em-
ployed. Fluoroscopy was used at the discretion of the phy-
sician performing insertion. Surgical insertion was per-
formed using either a standard balloon pump catheter
(Datascope) or one of the percutaneous balloon pump cath-
eters described, with the balloon pump catheter inserted
using an end to side Dacron graft to the femoral artery (a
transverse arteriotomy withoutan end to side graft was used
in one case).
Balloon pump insertion was considered successful if,
using the designated technique, the balloon catheter was
successfully inserted in the femoral artery initially chosen
for insertion. Whetheror not to abandonthe initiallychosen
femoral artery or the designated technique was decided by
the inserting physician in the interestof optimalpatientcare.
The insertion time, measured in minutes from the beginning
of the insertion procedure to the initiation of counterpul-
sation, was recorded in each case of successful insertion.
The time from request for balloon pump insertion to initi-
ation of counterpulsation , also measured in minutes, was
recorded in each case of nonelective successful insertion.
After successful balloon pump insertion, full dose intra-
venous heparin was administered to maintain the partial
thromboplastin time at 1.5 to 2.5 times the control time.
Patients undergoing cardiac or general surgery did not re-
ceive heparin after surgery; most of these patients received
low molecular weight dextran (20 mllh) after surgery until
the balloon pump was removed. Cephalothin (I g intrave-
nously every 6 hours) was administered while the balloon
pump was in place as longas there was no history of allergy
to penicillin .
Balloon pump removal. A balloonpump inserted using
the percutaneous technique was removed percutaneously in
all but three cases; with continuous digital pressure applied
over the femoral artery for 20 to 30 minutes to obtain he-
mostasis. Protamine sulfate (50 mg) was administered in-
travenously immediately beforeremoval of the percutaneous
balloon pump in the majority of patients receiving heparin
at that time. In three cases, a balloonpumpcatheter inserted
percutaneously was surgically removed, followed by Fo-
garty thrombectomy. In these cases, the presence of throm-
bus in the femoral or iliac artery had been suspected before
balloon pump removal.
Balloon pumps inserted surgically were removed with a
second surgical procedure .. at the timeof removal, a Fogarty
embolectomy catheter was advanced from the femoral ar-
teriotomy site proximally to the abdominal aorta and distally
down the branches of the femoral artery to retrieve any
thrombotic material before oversewing of the prosthetic graft.
The presence or absence of thrombus during removal of
each surgically inserted balloon pump was recorded.
Patient follow-up. Hemoglobin and hematocrit values
were measured 24 hours after balloon pump insertion, then
dailyor moreoften as clinicallywarranted. Ankle/arm index
values were measured 12 to 24 hours after balloon pump
insertion. Measurement of postinsertion ankle/arm index
was performed with the balloon pump turned off for the
brief period of time necessary for pressure measurement,
using direct radial artery pressure for arm systolic pressure.
Details (}f the hospital course for each patient were re-
corded, including I) duration of balloon pumpsupport (days);
2) presence of hemodynamic criteria for cardiogenic shock
at any time during balloon pump support (including post-
cardiac surgical low output syndrome); 3) therapy with an
inotropic agent at any time during balloon pump support;
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Table I. Study Population
Percutaneous
(n = 51)
Surgical
( n = 50 ) p Value
ysis. Significance of data was determined at the level of
probability (p) less than 0.05.
4) cardiac surgery after balloon pump insertion, and 5) pa-
tient death during balloon pump support. Complications of
balloon pump insertion were noted, as was the administra-
tion of blood transfusion at any time during balloon pump
support (excluding transfusion after cardiac or general sur-
gery).
Statistical analysis. Data for patient age, height and
weight, hemoglobin and hematocrit values. ankle/arm index
values. duration of balloon pump support, insertion time
and time from request to initiation of counterpulsation are
presented as mean values ± I SO. Hemoglobin and he-
matocrit values obtained after cardiac or general surgery or
after blood transfusion were excluded from analysis. An-
kle/arm index values greater than 1.00 were considered to
be 1.00 for the purpose of statistical analysis. Postinsertion
ankle/arm index values were included only for patients in
whom balloon pump insertion was considered successful
and in whom the balloon pump catheter was still in place
at the time of the post-insertion measurements. Comparisons
were made between percutaneous insertion and surgical in-
sertion groups for mean values and between cardiologists
and surgeons for mean percutaneous insertion time using
the nonpaired t test. Comparisons were made between prein-
sertion and postinsertion ankle/arm index data using the
paired Student' s t test. Comparisons were made between
the percutaneous and surgical groups in terms of ratio of
men to women, frequency of various indications for balloon
pump insertion, frequency of various hospital course char-
acteristics, insertion success rate, vascular complication rate
and incidence of blood transfusion, using chi-square anal-
Age (yrl
Men ( 'if.)
Women (%)
Height (inches)
Weight ( lb )
62 :!: II
65
35
66 :!: 5
165 :!: 28
61 :!: 9
70
30
66 :!: 10
16K :!: 3lJ
NS
NS
NS
NS
NS
Results
The percutaneous and surgical groups were similar in
terms of mean patient age, height and weight and sex ratio
(Table I ) . The two groups also had a similar distribution
of indications for balloon pump insertion (Table 2). Unstable
or postinfarction angina was the primary indication for bal-
loon pump insertion for the majority of patients in both
groups.
There was no difference between the percutaneous and
surgical groups in terms of duration of balloon pump sup-
port, percentage of patients manifesting hemodynamic cri-
teria for cardiogenic shock, therapy with inotropic agents,
requirement for subsequent cardiac surgery or expiration
during balloon pump support (Table 3) .
Percutaneous Technique
Success rate. Of the 51 patients in the percutaneous
group. 46 had percutaneous insertion attempted using a wire-
guided percutaneous catheter and 5 had percutaneous in-
sertion attempted using a non-wire-guided catheter. Per-
cutaneous insertion was successful in 41 (89%) of the 46
cases involving a wire-guided catheter and in 4 (80%) of
the 5 cases in which a nonwire-guided catheter was used
(p = NS). Overall. percutaneous insertion was successful
in 88% of patients in the percutaneous group. Fluoroscopy
was used for 21(46%) of the 46 patients with a wire-guided
percutaneous insertion procedure; insertion was successful
in 19 (90%) of the 21 cases in which fluoroscopy was used,
and was successful in 22 (88%) of the 25 cases in which
fluoroscopy was not used (p = NS).
Unsuccessful cases. Percutaneous insertion was unsuc-
cessful in six cases. Failure to advance the balloon catheter
was presumably related to severe aortoiliac atherosclerosis
in two cases; surgical insertion was subsequently attempted
through the same femoral artery in one of these cases, with-
out success. Percutaneous insertion was unsuccessful in two
Table 2. Indications for Intraaortic Balloon Pump Insertion
Percutaneous
(n = 51)
Surgical
(n = SO) p Value
Ml with card iogenic shock (%)
Unstable angina (%)
Post-MI angina (%)
Preoperative support (% )
MI with mitral regurgitation (% )
MI with ventricular septal defect (%)
Ventriculararrhythmia (%)
Other (%)
MI = myocardial infarction.
18
31
20
18
6
2
2
4
16
20
34
18
2
4
2
4
NS
NS
NS
NS
NS
NS
NS
NS
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Table 3. Hospital Course
Duration of [ABP (days)
Criteria for cardiogenic shock (%)
Inotropi c agents (% )
Cardiac surgery (%)
Expired durin g IABP support (%)
(ABP = inlraaortic balloon pump .
Percutan eous
(n = 51)
3.8 ± 2.7
61
61
43
22
Surg ical
(n = 50)
4.4 ± 2.6
66
77
52
12
p Value
NS
NS
NS
NS
NS
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cases because of inability to advance the guide wire initially
and in another case because of inability to advance the
introducer sheath over the guide wire past the aortic bifur-
cation and in an additional case because of inability to ad-
vance the balloon pump catheter through the indwelling
introducer sheath. A percutaneous balloon pump catheter
was successfully inserted through the same femoral artery
at a later date in this last case. Fluoroscopy was utilized in
two of the six unsuccessful cases.
The percutaneous insertion success rate was slightly higher
for cardiologists (9 1%) than for surgeons (82%); this dif-
ference was not statistically signifi cant.
Insertion time. The mean insertion time or the time
from the beginning of the insertion procedure to counter-
pulsation was 13 ± 8 minutes for percutaneous insertions .
Table 4. Major Complicati ons
The percutaneous insertion times for cardiologists (12 ± 8
minutes) and surgeons (13 ± 8 minutes) did not differ
significantly. The mean time from request for balloon pump
insertion to initiation of counterpulsation was 134 ± 51
minutes in patients with percutaneous insertion.
Major complications. Ten patients in the percutaneous
group developed lower limb ischemia requiring Fogarty
thrombectomy after balloon pump removal (Table 4).
Thrombectomy followed percutaneous balloon pump cath-
eter removal in seven patients and surgical removal in three
patients. In one of these patients it was discovered at the
time of thrombectomy that the balloon pump catheter had
been inadvertently inserted into the superficial femoral ar-
tery instead of the common femoral artery. The mean du-
ration of balloon pump support before thrombectomy in the
Percutaneous Surgical
No. of No. of
Compli cation Patient s % Patient s % p Value
Lower limb ischemia 10 20 2
requiring surgical
intervention
Severe lower limb 2 0
ischemia requir ing
immediate IABP
removal
Sepsi s with bacteremia 0 2
requiring vein patch
repair of femoral
artery
Sepsis with bacteremia 0 2 4
not requ iring vein
patch repair of
femoral artery
Wound infection 0 2
requi ring
debr idement
Cerebral embolus 0 2
Total major 11 22 6 12 NS
complications
Total major vascular 11 22 2 4 < 0.05
compl ications
IABP = intraaortic balloon pump.
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10 patients was 3.5 ± 2.1 days. This did not differ
significantly from the duration of balloon pump support
(3.7 ± 2.6 days) in the remaining 35 patients in the per-
cutaneous group who underwent successful insertion and
did not require thrombectomy. One patient in the percuta-
neous group developed severe lower limb ischemia almost
immediately after balloon pump insertion and required im-
mediate balloon pump removal and termination of balloon
pump support.
Minor complications. Four patients (8%) in the per-
cutaneous group were found to have malposition of the
balloon pump catheter on chest X-ray film after insertion,
with the tip of the catheter either too high (in the left common
carotid artery) or too low (in the lower thoracic aorta or
abdominal aorta).
during routine surgical balloon pump removal in nine ad-
ditional patients in the surgical group. Becausethis occurred
as part of the routine removal procedure, these patients were
not considered to have had a vascular complication. Three
patients in the surgical group developed sepsis with bac-
teremia, including one patient who had vein patch repair of
the femoral artery and was considered to have had a vascular
complication. Bacteremia occurred, respectively, on day 3,
day 8 and day 9, of balloon pump support in these patients.
All three patients underwent cardiac surgery before the de-
velopment of clinical evidence of sepsis. Sepsis and bac-
teremia were probably related to balloon pump insertion in
one patient, in whom the organismdetected in blood cultures
was also detected in the balloon pump wound and on the
tip of the balloon pump catheter. In the other two patients,
Figure 1. Results of intraaortic balloon pump insertion using the
surgical technique. Surgical insertion was attempted using either
a standard surgical or percutaneous (Perc) catheter.
50 Attempted
~~~~
Surgical Technique
Success rate. Of the 50 patients in the surgical group
(Fig. 1),43 had surgical insertion attempted using a surgical
balloon pump catheter initially; insertion of this catheter
was successful in 33 patients and unsuccessful in 10. Sur-
gical insertion using a percutaneous catheter was then at-
tempted in these 10 patients and was successful in 8 of them
and unsuccessful in 2. Unsuccessful insertion was related
to severe aortoiliac atherosclerosis in both cases (Fig. 2).
Surgical insertion was attempted with a percutaneous cath-
eter initially in seven patients in the surgical group and was
successful in every patient. Overall, surgical insertion using
either a surgical catheter or a percutaneous catheter was
successful in 96% of patients in the surgical group.
Insertion time. The mean insertion time for surgical
insertions was 31 ± 16 minutes, whereas the mean time
from request to initiation of counterpulsation was 163 ±
66 minutes.
Major complications. One patient in the surgical group
developed lower limb ischemia requiring a repeat Fogarty
thrombectomy procedure as well as anterior compartment
fasciotomy after the routine surgical balloon pump removal
procedure. Thrombus was retrieved with a Fogarty catheter
Figure2. Autopsy specimen from one of the two patients inwhom
anintraaortic balloon pump could not besuccessfully inserted using
the surgical technique. Severe atherosclerosis involving the ab-
dominal aorta and iliac arteries is seen. Insertion was attempted
in the left femoral artery. using first a standard surgical balloon
pump catheter and then a wire-guided percutaneous catheter with
fluoroscopy. Insertion in the right femoral artery was not at-
tempted.
UNSUCCESSFUL 2(4%)
Standard surgical catheter
/ u"J:",,-
-: /,/Pere"'i:attempte7
Perc catheter
SUCCESSFUL 48(96%)
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the organism detected in blood cultures was not detected in
the balloon pump wound or on the tip of the balloon pump
catheter. and sepsis and bacteremia can be considered only
as possible balloon pump complications. One patient in the
surgical group developed a wound infection that required
debridement as well as antibiotic therapy. Another patient
in the surgical group developed disorientation and left hand
weakness during balloon pump support, 6 days after inser-
tion, and it was believed that a small cerebral embolic event
had probably occurred. This patient had recent myocardial
infarction with left ventricular aneurysm. and therefore the
cerebral embolic event can be considered only a possible
balloon pump complication.
Minor complications. Five patients (10%) in the sur-
gical group were found to have catheter malpositionon chest
X-ray fi lm. Six patients (12%) had wound infection not
requiring debridement; one of these patients also had a lym-
phatic fi stula and another had a seroma. Excessive bleeding
or hematoma. or both, occurred in five patients ( 10%) .
Cellulitis developed in one patient, and balloon leak re-
quiring balloon pump catheter replacement occurred in one
patient.
Comparisons
Success rate. The overall surgical insertion success rate
(96%) was slightly higher than that for percutaneous inser-
tion (88%) , but this difference was not statistically signif-
icant.
Insertion time. The mean insertion time was signifi-
cantly lower for the percutaneous group ( 13 ± 8 minutes)
than for the surgical group (3 1 ± 16 minutes) (p < 0.001).
The time from request to initiation of counterpulsation was
also significantly lower for percutaneous (134 ± 51 min-
utes) than for surgical insertions ( 163 ± 66 minutes) (p <
0.05 ).
Vascular complications. No patient in either group had
clinically detectable aortic dissection, aortoiliac perforation,
lower limb amputation or pseudoaneurysm. Autopsy ex-
amination was performed on six patients (three percutaneous
and three surgical) who died during hospitalization and no
evidenceof clinically unsuspected aorticdissectionwas found .
The vascular complication rate was 22% for the percu-
taneous group and 4% for the surgical group (p < 0.05) .
The percutaneous vascular complication rate was also higher
than the corresponding surgical rate in both female (28 ver-
sus 13%) and male ( 18 versus 0%) subgroups, but these
differences were not statistically significant. The vascular
complication rate for women was higher than that for men
in both the percutaneous and surgical groups; these differ-
ences were also not significant.
Ankle/arm systolic pressure index. The percutaneous
and surgical groups did not differ significantly in terms of
preinsertion or postinsertion Doppler ankle/arm index on
the side of balloon pump insertion (Table 5). The prein-
sertion to postinsertion difference in ankle/arm index was
greater for the surgical group, but this difference was not
statistically signifi cant. The postinsertion ankle/arm index
was significantly lower than the preinsertion ankle/arm in-
dex in both the percutaneous and surgical groups.
Bleeding. The mean decrease in hemoglobin from before
to 24 hours after insertion was 0.8 ± 0.9 g/deciliter for
percutaneous and 1.6 ± 1.1 g/dl for surgical insertions
(p < 0.05) . The mean decrease in hematocrit from before
to 24 hours after insertion was 2.3 ± 3.0% for percutaneous
and 5.2 ± 3.3% for surgical patients (p < 0.005 ). Blood
transfusion (excluding that after cardiac or general surgery)
was required for 18 (36%) of 50 patients in the surgical
group compared with 4 (8%) of 51 patients in the percu-
taneous group (p < 0.0 1).
Discussion
Previous studies. Major complication rates between 9
and 36% have been reported in various studies (2,8,19-23)
using the standard surgical technique for balloon pump in-
sertion. The initialencouraging reports of percutaneous bal-
loon pump insertion indicated major complication rates be-
tween 4 and 8% (12, 13), whereas subsequent studies reported
Table 5. A nk le/Arm S yst ol ic Pres sure Inde x Dat a
Percutaneous Surgical
(n = 51 ) (n = 50) P Value
AAI
Preinsert 0 .l:l9 ± (1 . 15 0 .95 :!: 0 . 10 NS
(43) (46)
Postin sert 0 .76 ± 0 .30 0 .71 ± 0 .25 NS
(35 ) (44 )
C.AAI 0 .15 ± 0.25 0 .2 1 :t 0.22 NS
(3 1) (4 1)
AAI = ankle/arm index on the side of balloon pump insertion; C.AAI = difference between preinse rtion
and postinsertion ank le/ann index on the side of balloon pump insertion . Numbers in parentheses represent
numbers of patients with applicable data.
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rates between 7 and 15% (24-30), A number of nonran-
domized studies (5,14-18) have compared the percutaneous
and surgical techniques, Bemis et al. (14) found a lower
complication rate with the percutaneous technique (5 versus
19% for surgical insertion), In a study by Alcan et al. (15),
wire-guided percutaneous insertion and surgical insertion
were associated with almost identical major complication
rates (15.2 and 15.6%, respectively). Similarly, percuta-
neous and surgical major complication rates did not differ
significantly in a study by Shahian et ai. (17) (17.4 and
12.2%, respectively). Percutaneous insertion was associated
with a higher major complication rate (9.9 versus 3.5% for
surgical insertion) in a study by Pennington et ai. (5) and
was associated with a higher vascular complication rate (27
versus 14% for surgical insertion) in a report by Gottlieb et
al. (18).
Comparing balloon pump insertion complication rates
from different studies is difficult. Complication rates depend
on the physician's level of skill and experience, how com-
plications are defined and whether data are obtained pro-
spectively or retrospectively. The relative frequencies of
various indications for balloon pump insertion also influence
complication rates; patients with cardiogenic shock have a
higher complication rate than do patients undergoing balloon
pump insertion before elective coronary artery bypass graft
surgery (20). Assessment of complication rates is also dif-
ficult because complications associated with unsuccessful
balloon pump insertion have not always been included in
reports, which leads to an underestimation of true compli-
cation rates. Also, some patients die soon after balloon pump
insertion and before complications can be recognized clin-
ically (22).
Vascular complications. Our randomized comparison
of the percutaneous and surgical techniques of intraaortic
balloon pump insertion indicates that percutaneous insertion
is associated with a higher incidence of vascular compli-
cations, particularly with the need for Fogarty thrombec-
tomy after balloon pump removal. There are a number of
possible explanations for this difference in vascular com-
plication rates. Greater trauma to the femoral artery could
possibly occur with the percutaneous technique. The balloon
pump catheter is occasionally inserted inadvertently into the
superficial femoral artery instead of the common femoral
artery with the percutaneous technique, predisposing the
patient to thrombus development because of the smaller
arterial lumen size. This problem occurred in only one of
the percutaneous cases requiring Fogarty thrombectomy after
balloon pump removal. The percutaneous technique, using
a wire-guided catheter, could make possible successful bal-
loon pump insertion in some patients with severe aortoiliac
occlusive disease in whom surgical insertion with a standard
balloon pump catheter would not be possible, predisposing
to thrombus development in the iliac or femoral artery. This
possibility does not appear to explain the difference in vas-
cular complication rates, because the surgical insertion suc-
cess rate in this study was so high.
Our finding that thrombus was retrieved from the femoral
or iliac artery during routine balloon pump removal in nine
additional patients with surgical insertion (who are not con-
sidered to have had a vascular complication) suggests that
the percutaneous and surgical techniques have similar rates
of thrombus development in the femoral or iliac artery. The
preinsertion to postinsertion difference in ankle/arm index
in the percutaneous group did not differ significantly from
that in the surgical group, suggesting that there is no major
difference in the degree of femoral artery obstruction be-
tween the two techniques. The fact that an attempt is made
routinely to retrieve thrombotic material with a Fogarty em-
bolectomy catheter during removal of a surgically inserted
balloon pump catheter probably accounts for the difference
in vascular complication rates between the two techniques.
The percutaneous balloon pump removal technique that
we used in our investigation was the technique in general
use when the study was done. A modified removal technique
has evolved (13,24,29), involving manual compression of
the femoral artery below the insertion site at the time of
balloon pump catheter removal while a jet of blood is al-
lowed to flush the artery for I to 2 seconds, followed by
compression of the artery above the insertion site with Dop-
pler monitoring of ankle arterial blood flow. This newer
removal technique may reduce the incidence of percuta-
neous balloon pump lower limb ischemic complications,
particularly ischemia secondary to embolism of thrombotic
material from the common femoral artery to a more distal
arterial segment of the lower limb at the time of balloon
pump catheter removal. Most of the patients in the percu-
taneous group in our study who developed a lower limb
ischemic complication requiring surgical intervention de-
veloped evidence of lower limb ischemia on physical ex-
amination and by monitoring of the Doppler ankle/arm index
before balloon pump catheter removal. Therefore, we do
not believe that the use of this newer removal technique in
our study would have substantially altered the results. One
patient in our study did develop evidence of lower limb
ischemia only after percutaneous balloon pump catheter re-
moval and subsequently underwent popliteal artery embo-
lectomy. Use of the newer removal technique might have
prevented the complication that occurred in this patient.
Previous studies have reported significantly higher bal-
loon pump complication rates in women than in men, which
were attributed to the smaller size of femoral arteries in
women (17,18). In our study, vascular complication rates
were higher in women in both the percutaneous and surgical
groups, but this difference was not statistically significant.
Clinical implications. Although the percutaneous tech-
nique is associated with a higher vascular complication rate
than is the surgical technique, the incidence of major in-
fectious complications appears to be lower with percuta-
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neous (no cases) than with surgical insertion (one definite
case, one probable case and two possible cases). We also
found less blood loss and a lower requirement for blood
transfusion with the percutaneous technique, which could
have important clinical implications .
The percutaneous technique is rapid and technically easy .
Its shorter insertion time provides an important advantage
in certain situations, such as cardiac catheterization labo-
ratory emergencies and cardiopulmonary resuscitation .
However. when the time from request for balloon pump
insertion to initiation of counterpulsation is taken into ac-
count, the difference in speed between the two techniques
becomes relatively less important in most clinical settings .
This study failed to demonstrate a significant difference
in insertion success rate between the percutaneous and sur-
gical techniques. The study also failed to show a relation
between the use of fluoroscopy and successful insertion with
the percutaneous technique. For the majority of patients
undergoing balloon pump insert ion, both the percutaneous
and surgical techniques are efficacious, with or without fluo-
roscop y. Nevertheless, we believe that on occasion, espe-
cially in patients with severe athero sclerosis or tortuosity
involving the aortoiliac segment, the percutaneous technique
with fluoroscopy offers a greater chance of successful in-
sertion than does either the percutaneous technique without
fluoroscopy or the surgical technique . We also believe that
the use of the percutaneous technique with fluoroscopy re-
duces the risk of aortic dissection or aortoiliac perforation ,
although we were unable to demonstrate this in our study
(neither complication occurred) .
Surgical removal ofpercutaneously inserted balloon pump
catheters is not routinely indicated . Monitoring of the status
of the lower limb circulation with physical examination and
Doppler ankle/arm pressure index measurements will iden-
tify those patients who require Fogarty thrombectomy after
percutaneous removal of a balloon pump catheter. Percu-
taneou s removal is preferable because of its ease, conve-
nience and probable lower risk of infection for patients who
do not develop thrombus in the iliac or femoral artery.
Recent technical advances may lead to a decrease in
percutaneous balloon 'pump vascular complication rates in
the near future . Percutaneous balloon pump catheters are
now available in the 1O.5F size (wire-guided) and 8.5F size
(nonwire-guided), and use of these smaller catheter sizes
could reduce the incidence of thrombus development in the
femoral or iliac artery. A 15 inch (38 ern) introducer sheath
is also available; use of this longer sheath may increase the
insertion success rate and may further decrease the alread y
low incidence of aortic dissection and aortoiliac perforation ,
especially in patients with severe atherosclerosis or tor-
tuosity involving the aortoiliac segment (14) .
Conclusion. The percutaneous and surgical techniques
for intraaortic balloon pump insertion are associated with
similar insertion success rates. Percutaneous insertion is
faster and easier than is surgical insertion. However, the
percutaneous technique is associated with a higher incidence
of vascular complications, particularly those requiring Fo-
garty thrombectomy after balloon pump removal. The fact
that Fogarty thrombectomy is attempted routinely during
removal of a surgically inserted balloon pump probably
accounts for the difference in vascular complication rates
between the two techniques . Lower limb circulation must
be monitored carefully for signs of ischemia after percu-
taneous balloon pump insertion and after balloon pump re-
moval. Monitoring should include both clinical observation
and Doppler monitoring of arm and leg pressures .
We express gratitude to Denec ia Getaw Edwards for expert secretarial
assistance.
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